BMB's 75th Anniversary Symposium

BMB’s 75th Anniversary Symposium

Posted on June 20, 2025

We are delighted to invite you to the Department’s 75th Anniversary Symposium, taking place on October 24, 2025. Please mark your calendars!

Since our founding in 1950 alongside the Faculty of Medicine, our Department has contributed to groundbreaking scientific achievements—from decoding the genetic code to Nobel Prize-winning advances in site-directed mutagenesis. This special event will celebrate our legacy, highlight exciting current research, and offer a look ahead at the future of biochemistry and molecular biology at UBC.

The day will feature scientific talks, panel discussions, and social events. Details on registration will be shared soon.

We look forward to celebrating this milestone with you.

Read More | No Comments

PhD Exit Seminar: Karlie Edwards

Posted on June 13, 2025

June 30, 2025 from 2:30 – 3:30 in LSC#3

Read More | No Comments

Our Faculty Proudly Supporting UBC’s AI Initiative for Better Health Care

Posted on June 12, 2025

Read More | No Comments

BMB Research Seminar: Dr. Ben Montpetit

Posted on June 11, 2025

June 19, 2025, from 3:30 PM to 4:30 PM at LSC 3 & Zoom

Read More | No Comments

BMBDG Seminar: Dr. Eden Fussner-Dupas and Dr. Lindsay Rogers

Posted on May 28, 2025

June 2, 2025 from 2:30 PM to 3:30 PM at LSC 3 & Zoom

Read More | No Comments

Congratulations to the BMB Class of 2025!

Posted on May 27, 2025

Read More | No Comments

World’s First Personalized CRISPR Therapy for Genetic Disease Enabled by Groundbreaking Research at BMB

Posted on May 23, 2025

A groundbreaking milestone in genetic medicine has been reached at the Children’s Hospital of Philadelphia, where a baby with a devastating genetic condition received the world’s first personalized CRISPR-based gene therapy. This therapy was uniquely tailored to correct the child’s specific disease-causing mutation.

Crucially, the treatment was delivered using lipid nanoparticles (LNPs) developed by Acuitas Therapeutics—a company co-founded in 2009 by Dr. Pieter Cullis, a professor in our Department of Biochemistry and Molecular Biology (BMB). Dr. Cullis is internationally recognized as a pioneer in LNP research and development. His foundational and translational work in this field laid the essential groundwork for this medical breakthrough.

This landmark success marks a pivotal moment in precision medicine, opening the door to the treatment of many other monogenic rare diseases. The Department proudly congratulates Dr. Cullis for his visionary contributions that continue to shape the future of genetic therapies.

Learn More

Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease

A Baby Receives the First Customized CRISPR Treatment